{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18(1)"],"submitter":["Curatola A"],"pubmed_abstract":["<h4>Background</h4>Out-of-hospital cardiac arrest (OHCA) is one of the most dramatic events in pediatric age and, despite advanced neurointensive care, the survival rate remains low. Currently, no effective treatments can restore neuronal loss or produce significant improvement in these patients. Nerve Growth Factor (NGF) is a neurotrophin potentially able to counteract many of the deleterious effects triggered by OHCA. Transcranial Direct Current Stimulation (tDCS) has been reported to be neuroprotective in many neurological diseases, such as motor deficit and cognitive impairment. Children with the diagnosis of chronic vegetative state after OHCA were enrolled. These patients underwent a combined treatment of intranasal administration of human recombinant NGF (hr-NGF), at a total dose of"],"journal":["Biology direct"],"pagination":["24"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10170696"],"repository":["biostudies-literature"],"pubmed_title":["Combined treatment of nerve growth factor and transcranical direct current stimulations to improve outcome in children with vegetative state after out-of-hospital cardiac arrest."],"pmcid":["PMC10170696"],"pubmed_authors":["Granata G","Staccioli S","Capossela L","Ferretti S","Manni L","Cocciolillo F","Piastra M","Gatto A","Curatola A","Conti G","Mantelli F","Graglia B","Calcagni ML","Soligo M","Castelli E","Romeo T","Pani M","Chiaretti A","Di Giuda D","Romeo DM","Mancino A","Marca GD"],"additional_accession":[]},"is_claimable":false,"name":"Combined treatment of nerve growth factor and transcranical direct current stimulations to improve outcome in children with vegetative state after out-of-hospital cardiac arrest.","description":"<h4>Background</h4>Out-of-hospital cardiac arrest (OHCA) is one of the most dramatic events in pediatric age and, despite advanced neurointensive care, the survival rate remains low. Currently, no effective treatments can restore neuronal loss or produce significant improvement in these patients. Nerve Growth Factor (NGF) is a neurotrophin potentially able to counteract many of the deleterious effects triggered by OHCA. Transcranial Direct Current Stimulation (tDCS) has been reported to be neuroprotective in many neurological diseases, such as motor deficit and cognitive impairment. Children with the diagnosis of chronic vegetative state after OHCA were enrolled. These patients underwent a combined treatment of intranasal administration of human recombinant NGF (hr-NGF), at a total dose of","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-26T17:19:46.374Z","creation":"2024-11-20T22:15:48.337Z"},"accession":"S-EPMC10170696","cross_references":{"pubmed":["37165387"],"doi":["10.1186/s13062-023-00379-5"]}}